| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |